Trial intelligence / Profile preview

Dexmedetomidine versus haloperidol for prevention of delirium after coronary artery bypass surgery

IRCT20171104037209N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in delirium comparing Dexmedetomidine arm with Haloperidol arm (2 arms). Primary endpoints: Incidence of delirium, Severity of delirium and 6 more. Started Oct 2016; status: completed.

02

Drugs

dexmedetomidinehaloperidol
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT20171104037209N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171104037209N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call